Jessica L Turnier, MD, MS
Manage Your Profile
About
I am a Pediatric Rheumatologist and physician scientist at the University of Michigan working to improve outcomes for children with rheumatic disease. I developed a multidisciplinary juvenile myositis clinic to expand access to state-of-the-art clinical care and better integrate research with clinical care. I started a juvenile myositis patient and family advisory council and work to integrate patient experience and engagement into clinic and research developments.
Qualifications
-
Pediatric Rheumatology FellowCincinnati Children's Hospital Medical Center, Pediatrics, Cincinnati, United States
2014 - 2017
Clinical Fellowship
-
Pediatric ResidentChildren's Hospital Colorado, Pediatrics, Aurora, United States
2011 - 2014
Residency
Research Overview
My research focuses on improving clinical care for children with myositis and lupus. I study skin disease in pediatric myositis and lupus to identify novel disease mechanisms, biomarkers and treatment targets. I use translational, molecular and bioinformatic approaches to understand how we can develop precision medicine care for myositis and lupus patients. I currently lead two multicenter studies to understand the molecular and cellular basis of treatment response in juvenile myositis.
Recent Publications
-
Wang C, Boykin M, Oberstaedt B, Shemke J, Turnier J, Janssen E. 2026 May 7;Proceeding / Abstract / PosterEvaluation of Peripheral B-and T-cell subsets Using Spectral Flow Cytometry and Anti-drug Antibody Levels in Youth with Systemic Lupus Erythematosus and Dermatomyositis Treated With Rituximab
-
Turnier J. 2026 Mar 16;PresentationHands-On Capillaroscopy Workshop: Practical Applications in Myositis Diagnosis and Management
-
Turnier J. 2025 Oct 16;PresentationMapping Genes in Space to Illuminate Disease Biology in Juvenile Dermatomyositis
-
Grant K, Matossian S, Rosek A, Sturza J, Chen L, Madubata C, Barnett D, Neely J, Torok K, Kahlenberg JM, Tsou E, Turnier J. 2026 Mar 24;Proceeding / Abstract / PosterEndothelial cell mediators reflecting angiopoietin and interferon pathway activation characterize juvenile dermatomyositis disease activity and autoantibody subgroups
-
Rynda A, McClellan N, Chen L, Kim S, Neely J, Turnier J. 2026 Mar 24;Proceeding / Abstract / PosterNailfold Capillaroscopy Changes Across a Dual Center Cohort of Juvenile Dermatomyositis Patients
-
Chen L, Li Q, Grant K, Rynda A, Tsoi L, Kahlenberg JM, Turnier J. 2026 Mar 24;Proceeding / Abstract / PosterSingle-Cell Profiling Reveals Interferon-High Proliferation in JDM versus NFκB-Driven Inflammation in cSLE across Naive B and CD56dim CD16+ NK Cells
-
Osborne GA, Zhang L, Ma F, Gharaee-Kermani M, Turnier JL, Victory AN, Hurst A, Xu B, Pedersen EA, Bogle R, Berthier CC, Ognenovski V, Nakamura M, Tsoi LC, Billi AC, Gudjonsson JE, Klein B, Tsou P-S, Kahlenberg JM. Sci Transl Med, 2025 Dec 24; 17 (830): eaea9007Journal ArticleDermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation.
DOI:10.1126/scitranslmed.aea9007 PMID: 41442501 -
Swaminathan S, Naik N, Shenoi S, Vandenbergen S, Turnier JL, Zheng Z, Neely J, Andrews JS, Lood C. Pediatric Rheumatology, 2025 Dec 1; 23 (1):Journal ArticleNeutrophil lymphocyte ratio as a marker of skin disease activity in older children with juvenile dermatomyositis
DOI:10.1186/s12969-025-01172-6 PMID: 41286892